Alpha Tau Medical (DRTS) officer schedules next stock sale under 10b5-1 plan

Rhea-AI Filing Summary

Alpha Tau Medical Ltd. (DRTS) has a notice from officer Raphael (Raphi) Aryeh Levy to sell 5,000 Ordinary Shares of the company under Rule 144. The broker is Oppenheimer & Co. Inc., and the shares are tied to a cash exercise of employee stock options scheduled for 08/21/2026.

The notice lists prior Rule 144 sales by Levy over the past three months, including multiple transactions in June, July, and August 2026 with aggregate dollar amounts disclosed for each trade. The sales are made pursuant to a Rule 10b5-1 trading plan adopted on 03/24/2026.

Key Figures

Shares to be sold: 5,000 Ordinary Shares Aggregate market value of planned sale: $71,800.00 CUSIP or security identifier: 88009737 +5 more

8 metrics

Shares to be sold 5,000 Ordinary Shares Planned Rule 144 sale listed in the securities information section

Aggregate market value of planned sale $71,800.00 Reported for the 5,000 Ordinary Shares in the planned transaction

CUSIP or security identifier 88009737 Identifier listed with the Ordinary Shares in the securities information table

Prior sale on 06/23/2026 17,500 Ordinary Shares for $167,051.00 Securities sold during the past 3 months section

Prior sale on 06/25/2026 20,000 Ordinary Shares for $220,004.00 Securities sold during the past 3 months section

Prior sale on 08/11/2026 17,730 Ordinary Shares for $248,276.74 Securities sold during the past 3 months section

Rule 10b5-1 plan adoption date 03/24/2026 Stated in the remarks as the adoption date of the trading plan

Date of Notice 08/21/2026 Filed as the date of the Form 144 notice

Key Terms

Rule 144, Rule 10b5-1 trading plan, employee stock options, Ordinary Shares

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Rule 10b5-1 trading plan regulatory

"The securities are being sold pursuant to a Rule 10b5-1 trading plan adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

employee stock options financial

"Shares acquired upon exercise of employee stock options"

Employee stock options are contracts that give workers the right to buy a company's shares at a set price sometime in the future, like a coupon that lets you purchase stock at today’s price later on. Investors care because they align employees’ incentives with company performance and create a potential future claim on shares that can reduce existing owners’ percentage and add to a company’s reported compensation costs.

Ordinary Shares financial

"Ordinary Shares | 08/21/2026 | Shares acquired upon exercise"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

Who is selling Alpha Tau Medical Ltd. (DRTS) shares in this Form 144?

The notice relates to Raphael (Raphi) Aryeh Levy, an officer of Alpha Tau Medical Ltd., who has filed to sell company Ordinary Shares under Rule 144 through broker Oppenheimer & Co. Inc.

How many DRTS shares are proposed to be sold under this Form 144?

The filing covers a proposed sale of 5,000 Ordinary Shares of Alpha Tau Medical Ltd. These shares are associated with a cash payment upon exercise of stock options and are scheduled in the notice for 08/21/2026.

What is the aggregate market value of the DRTS shares in the planned Form 144 sale?

For the 5,000 Ordinary Shares covered by this notice, the aggregate market value reported is $71,800.00. This amount appears in the securities information section alongside the planned sale details.

Were there recent sales of DRTS shares by Raphael Levy before this Form 144?

Yes. The notice lists several prior sales in the past three months, including 17,500 shares on 06/23/2026, 20,000 shares on 06/25/2026, and other transactions in June, July, and August 2026 with their dollar amounts disclosed.

Is the DRTS Form 144 sale under a trading plan?

Yes. The filing states that the securities are being sold pursuant to a Rule 10b5-1 trading plan that was adopted on 03/24/2026, which governs the timing and amount of the reported sales.

What type of securities of DRTS are involved in this Form 144?

All transactions disclosed in the notice involve Ordinary Shares of Alpha Tau Medical Ltd. This includes the 5,000 shares to be sold following the exercise of employee stock options and the prior sales in the last three months.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/21/2026 - 05:01 PM Accepted by SEC EDGAR 08/21/2026 - 05:00 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001968095
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Alpha Tau Medical Ltd.
SEC File Number	001-41316
Address of Issuer	KIRYAT HAMADA 5 JERUSALEM ISRAEL 9777605
Phone	972-3-577-4115
Name of Person for Whose Account the Securities are To Be Sold	Raphael (Raphi) Aryeh Levy
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	5000	71800.00	88009737	08/21/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	08/21/2026	Shares acquired upon exercise of employee stock options	Alpha Tau Medical Ltd.			5000	08/21/2026	Cash payment upon exercise of stock options

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Raphael (Raphi) Aryeh Levy KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary Shares	06/23/2026	17500	167051.00
Raphael (Raphi) Aryeh Levy KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary Shares	06/25/2026	20000	220004.00
Raphael (Raphi) Aryeh Levy KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary Shares	06/30/2026	20000	240044.00
Raphael (Raphi) Aryeh Levy KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary Shares	07/01/2026	2127	27691.20
Raphael (Raphi) Aryeh Levy KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary Shares	07/02/2026	17873	232397.26
Raphael (Raphi) Aryeh Levy KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary Shares	07/06/2026	2270	31782.50
Raphael (Raphi) Aryeh Levy KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary Shares	08/11/2026	17730	248276.74

144: Remarks and Signature

Remarks	The securities are being sold pursuant to a Rule 10b5-1 trading plan adopted on 03/24/2026
Date of Notice	08/21/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Raphael (Raphi) Aryeh Levy By: /s/ Liron Avigdor Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)